Turing

Discussion in 'Biotech Startups' started by anonymous, Sep 26, 2015 at 9:15 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    When will the layoffs and mass exodus begin? CCO has already resigned two months in. Many more to come. All that big money and bling predicated on price gouging and a CEO that is under criminal investigation. I'm sure many that joined are second guessing their decision. The almighty dollar often clouds one's judgment. For those of you that left solid organizations in search of more money you made a very poor decision. Should have done your due diligence and asked flat out how Martin was going to pay you all this money from a drug that generates very little revenue. You made your bed now sleep in it. Cocky arrogant suckers!!!
     

  2. anonymous

    anonymous Guest

    Next up: that breakthrough antibiotic penicillin. At only $5,000 a tablet!!
     
  3. anonymous

    anonymous Guest

    I was contacted about an RM job with Turing a few months back. When the recruiter told me to disregard some lawsuit the CEO was involved in from his other company I knew there was a problem. She kept telling me how young and cool the executive team was and that they come to meetings in jeans. I was dumbfounded. I asked her about the product and all she could really say was that it's and old drug with a new focus on toxoplasmosis in HIV patients. I have experience in that space and know the players. This one did not add up and I turned down the interview. My spidey senses were right. The CEO is an arrogant little twerp who single handedly brought down the biotech sector in a couple of weeks following some stupid statements during interviews. What an asshole. Billions of dollars lost in equity across the industry due to his flippant arrogance.
     
  4. anonymous

    anonymous Guest

    I smell a troll.... since I know they were not hiring RM/RDs and they did not exist in their business model or sales structure. Tsk tsk tsk.
     
  5. anonymous

    anonymous Guest

    Not a troll. They called me because another manager was being promoted or moved into another area. It never got further than the first phone call. I turned down the interview.
     
  6. anonymous

    anonymous Guest

    I've been getting calls from alot of different recruiters about Turing. Given they arent a large company and are working with 20 different recruiters is concerning. That means that there is no interest to work in this company. Given the history of the company and the recent actions of the CEO, I am not at all surprised. Their website also doesnt list a board of directors, but knowing of certain people at the company such as their head of operations should put up red flags for anyone looking to join.

     
  7. anonymous

    anonymous Guest

    I recently retired from pharma and saw this company in the news and realized that is where this woman i worked with went. Her name was Wendy C. What a basket case. If you think Turing itself is in trouble, wait until this woman is done with them.

     
  8. anonymous

    anonymous Guest

    Working with Wendy in the past and being a mother myself, as she used this excuse often for many of her shortcomings, I highly questioned her ability to lead or even make a meaningful impact to a program. She was always too stuck in the mindset that everyone is trying to out-maneuver her because she is a woman and the "glass ceiling" talk all the time. Its almost as if she was always plotting rather than putting in effort toward her job. She was just a drain to be around, both emotionally and from fostering a positive working environment perspective.

     
  9. anonymous

    anonymous Guest

    Did she walk around her former office at Retrophin wearing a stethoscope acting like an MD when clearly he was not.... odd people out there.


     
  10. anonymous

    anonymous Guest

    I interviewed there not too long ago. Long and short is that I dont plan on going there. The environment felt very sketchy and the hiring manager looked extremely nervous and worn down. She dodged alot of questions I had in regards to current working situation and what the plan was for the near and distant future.

     
  11. anonymous

    anonymous Guest

    AMEN lol

     
  12. anonymous

    anonymous Guest

    How's the Turing gig going? Oh that's right down the toilet. Martin Shkreli is off on a vacation courtesy of the Feds.
     
  13. anonymous

    anonymous Guest

    I hope that when people look at the resumes of those working at Turing, especially those in high level positions, they think twice about hiring those people who obviously had certain agenda's joining that shitty company under the leadership of a shittier person.
     
  14. anonymous

    anonymous Guest

    Looks like the CEO beat her to it. But if she is as bad as you say, I guess Karma does come back in wicked form.

     
  15. anonymous

    anonymous Guest

    Double Dipping at TURING:

    With all the distractions and lack of supervision I've chosen to Double Dip. It's a great way to maximize my/our time here!

    T out east and S out west are in it for ????????? You guessed it.

    One word of advice.....don't spend any bonus money put it in the bank.

    I still can not believe how much money I'm being paid to do nothing!

    Greats Deal on Earth!

    For now............
     
  16. anonymous

    anonymous Guest

    How can everyone from CEO down to the sales reps not be held accountable, both publicly and professionally for this business strategy? Everyone knew what was going on and what the vision was they were being asked to implement!

    The internal documents provided by Turing provide a window into its operations, showing that the skyrocketing drug price was part of the plan from the beginning. The company anticipated that the drug's main audience — the organized community of HIV patients whose weakened immune systems make them vulnerable to infection — could pose a problem because of their expert use of advocacy. But Turing thought that this could be kept under control by making sure patients had access to the drug even as the list price shot up. Although the company has emphasized that its patient assistance programs and discounts meant that no patients paid full price for the drug, the internal documents reveal that some did experience high co-pays, with at least one patient facing a $16,830 coinsurance payment and others charged $6,000.
     
  17. anonymous

    anonymous Guest

    Watching this hearing live on the internet. Retzlaff is getting absolutely shredding by Congress. She looks like a new born sheep in the middle of a pack of wolves. Pretty bad...
     
  18. anonymous

    anonymous Guest

    If you actually saw the internal documents you would know that the CEO and his cronies from Retrophin were the only ones involved in this pricing decision. The commercial leadership found out what the price was the morning of the "launch meeting" for the sales team. Since then Turing has slowly "melted" away based on the high percentage of patients in government programs (where price remains 1 penny a pill) and most commercial payers rejecting claims that are then covered by the patient assistance program. A path that would have been predictable if the commercial leaders in sales and marketing would have been able to use their experience to inform the pricing decision. Oh well....
     
  19. anonymous

    anonymous Guest

    Would hate to be you and the the word Turing on your resume. I feel dirty even saying that word and that's not an analogy. I know I am wrong and biased when I meet someone from that company but I just look at them differently and start to judge and make assumptions.